Examination Report |
1 | TM-1 | 06 Jan 2017 |
10 | Annexure -1 under rule 46 | 21 Aug 2020 |
10 | Evidence Affidavit Under Rule 46 (TOP) | 21 Aug 2020 |
11 | Annexure -1 under rule 46 | 21 Aug 2020 |
11 | Evidence Affidavit Under Rule 46 (TOP) | 21 Aug 2020 |
2 | Power of Attorney | 06 Jan 2017 |
3 | Reply to Exam Report (MIS-R) | 27 Jun 2017 |
4 | Affidavit | 24 Apr 2019 |
5 | Journal Copy | 02 Jul 2019 |
6 | TM-O(NOTICE OF OPPOSITION) | 26 Aug 2019 |
7 | TM-M(EXTENSION OF TIME) | 23 Mar 2020 |
8 | Annexure -1 under rule 46 | 25 Apr 2020 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 25 Apr 2020 |
9 | Annexure -1 under rule 46 | 25 Apr 2020 |
9 | Evidence Affidavit Under Rule 46 (TOP) | 25 Apr 2020 |
1 | Dispatching of Examination Report for : 3452078 | 4835674 | 2088416 | 15 Jun 2017 |
2 | Hearing Notice (Show Cause) | 7755120 | 3795687 | 08 Feb 2019 |
3 | Tribunal Accepted Notice for : 3452078 | 8187531 | 4024182 | 29 Apr 2019 |
4 | Opposition Notice | 8978001 | 4413942 | 24 Sep 2019 |
5 | Opposition Counter Statement | 9306514 | 4567017 | 27 Nov 2019 |
The application for Enzamide was made on 06 January 2017.
The trademark applicant for Enzamide is INTAS PHARMACEUTICALS.
Enzamide is applied in class(es) 5.
Application for Enzamide is on Opposed stage.
Application Id allotted to Enzamide is 3452078.
Trademark agent or attorney for the application is Y. J. Trivedi & Co.
Enzamide filed with the Intellectual property office as a WORD.